Lexeo Therapeutics logo

Lexeo Therapeutics

LXEO | NASDAQ
Chart Builder DCF Calculator
$3.23
+$0.36 (+12.54%)
At close: Nov 16, 2026, 4:00 PM ET
$3.20
-$0.03 (-0.93%)
After-hours: Nov 16, 2026, 7:59 PM ET
+12.54%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
34.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #659/1021 (Top 65%)

Key Statistics

Market Data

Market Cap $265.14M
1D Range
3.00 4.30
52W Range
2.63 10.63

Valuation (TTM)

PE -2.81
PB 1.13
EV/EBITDA -0.71

Valuation (NTM)

Forward PE N/A
Forward PEG 0.06
Price Target $19.50
Loading financial charts...

Profile

Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features se...

Sector Healthcare
Industry Biotechnology
Employees 63
IPO Date Nov 3, 2023
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$19.50
Upside
+503.72%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.